EU Advocate General backs pharma challenge to wastewater cost-sharing rule

An EU Advocate General recommended annulling part of the Urban Wastewater Treatment Directive that requires drugmakers to finance 80% of treatment costs. This is a legal opinion, not final, but signals a potential reversal of the extended producer responsibility scheme. If adopted, it would shift financial burden back to public utilities and reduce regulatory cost pressure on pharma.